Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

J Clin Lipidol. 2011 Jun;5(3 Suppl):S30-7. doi: 10.1016/j.jacl.2011.03.453. Epub 2011 Apr 5.

Authors

Stephen R Daniels¹, Samuel S Gidding, Sarah D de Ferranti; National Lipid Association Expert Panel on Familial Hypercholesterolemia

Affiliation

¹ Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO 80045, USA. [email protected]

PMID: 21600527
DOI: 10.1016/j.jacl.2011.03.453

No abstract available

Publication types

Practice Guideline

MeSH terms

Adolescent
Atherosclerosis / etiology
Child
Cholesterol, LDL / blood
Coronary Disease / etiology
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Hyperlipoproteinemia Type II / complications
Hyperlipoproteinemia Type II / diagnosis*
Hyperlipoproteinemia Type II / drug therapy
Mass Screening
Risk Assessment
Risk Factors

Substances

Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors